Despite a superior revenue outlook, the company isn't tradin...
Despite a superior revenue outlook, the company isn't trading at a higher P/S due to potential risks like not meeting analysts' revenue projections in tough industry conditions. Investors anticipate future revenue volatility.
Take Care Before Diving Into The Deep End On Bio-Rad Laboratories, Inc. (NYSE:BIO)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment